Cargando…

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

The annual “Antibody Industrial Symposium”, co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28–29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or r...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, Ana, Alvarez-Vallina, Luis, Bertoglio, Federico, Bouquin, Nicolas, Cornen, Stéphanie, Duffieux, Francis, Ferré, Pierre, Gillet, Raphaëlle, Jorgensen, Christian, Leick, Mark B, Maillère, Bernard, Negre, Hélène, Pelegrin, Mireia, Poirier, Nicolas, Reusch, Dietmar, Robert, Bruno, Serre, Guy, Vicari, Alain, Villalba, Martin, Volpers, Christoph, Vuddamalay, Gavin, Watier, Hervé, Wurch, Thierry, Zabeau, Lennart, Zielonka, Stefan, Zhang, Baolin, Beck, Alain, Martineau, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187075/
https://www.ncbi.nlm.nih.gov/pubmed/37184206
http://dx.doi.org/10.1080/19420862.2023.2211692
_version_ 1785042680256921600
author Antunes, Ana
Alvarez-Vallina, Luis
Bertoglio, Federico
Bouquin, Nicolas
Cornen, Stéphanie
Duffieux, Francis
Ferré, Pierre
Gillet, Raphaëlle
Jorgensen, Christian
Leick, Mark B
Maillère, Bernard
Negre, Hélène
Pelegrin, Mireia
Poirier, Nicolas
Reusch, Dietmar
Robert, Bruno
Serre, Guy
Vicari, Alain
Villalba, Martin
Volpers, Christoph
Vuddamalay, Gavin
Watier, Hervé
Wurch, Thierry
Zabeau, Lennart
Zielonka, Stefan
Zhang, Baolin
Beck, Alain
Martineau, Pierre
author_facet Antunes, Ana
Alvarez-Vallina, Luis
Bertoglio, Federico
Bouquin, Nicolas
Cornen, Stéphanie
Duffieux, Francis
Ferré, Pierre
Gillet, Raphaëlle
Jorgensen, Christian
Leick, Mark B
Maillère, Bernard
Negre, Hélène
Pelegrin, Mireia
Poirier, Nicolas
Reusch, Dietmar
Robert, Bruno
Serre, Guy
Vicari, Alain
Villalba, Martin
Volpers, Christoph
Vuddamalay, Gavin
Watier, Hervé
Wurch, Thierry
Zabeau, Lennart
Zielonka, Stefan
Zhang, Baolin
Beck, Alain
Martineau, Pierre
author_sort Antunes, Ana
collection PubMed
description The annual “Antibody Industrial Symposium”, co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28–29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or radioelements) and also on new cell-based therapies, such as chimeric antigenic receptor (CAR)-T cells. The symposium, which brought together scientists from academia and industry, also addressed issues concerning the production of these molecules and cells, and the necessary steps to ensure a strong intellectual property protection of these new molecules and approaches. These two days of exchanges allowed a rich discussion among the various actors in the field of therapeutic antibodies.
format Online
Article
Text
id pubmed-10187075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-101870752023-05-17 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies Antunes, Ana Alvarez-Vallina, Luis Bertoglio, Federico Bouquin, Nicolas Cornen, Stéphanie Duffieux, Francis Ferré, Pierre Gillet, Raphaëlle Jorgensen, Christian Leick, Mark B Maillère, Bernard Negre, Hélène Pelegrin, Mireia Poirier, Nicolas Reusch, Dietmar Robert, Bruno Serre, Guy Vicari, Alain Villalba, Martin Volpers, Christoph Vuddamalay, Gavin Watier, Hervé Wurch, Thierry Zabeau, Lennart Zielonka, Stefan Zhang, Baolin Beck, Alain Martineau, Pierre MAbs Meeting Report The annual “Antibody Industrial Symposium”, co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28–29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or radioelements) and also on new cell-based therapies, such as chimeric antigenic receptor (CAR)-T cells. The symposium, which brought together scientists from academia and industry, also addressed issues concerning the production of these molecules and cells, and the necessary steps to ensure a strong intellectual property protection of these new molecules and approaches. These two days of exchanges allowed a rich discussion among the various actors in the field of therapeutic antibodies. Taylor & Francis 2023-05-15 /pmc/articles/PMC10187075/ /pubmed/37184206 http://dx.doi.org/10.1080/19420862.2023.2211692 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Meeting Report
Antunes, Ana
Alvarez-Vallina, Luis
Bertoglio, Federico
Bouquin, Nicolas
Cornen, Stéphanie
Duffieux, Francis
Ferré, Pierre
Gillet, Raphaëlle
Jorgensen, Christian
Leick, Mark B
Maillère, Bernard
Negre, Hélène
Pelegrin, Mireia
Poirier, Nicolas
Reusch, Dietmar
Robert, Bruno
Serre, Guy
Vicari, Alain
Villalba, Martin
Volpers, Christoph
Vuddamalay, Gavin
Watier, Hervé
Wurch, Thierry
Zabeau, Lennart
Zielonka, Stefan
Zhang, Baolin
Beck, Alain
Martineau, Pierre
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
title 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
title_full 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
title_fullStr 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
title_full_unstemmed 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
title_short 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
title_sort 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187075/
https://www.ncbi.nlm.nih.gov/pubmed/37184206
http://dx.doi.org/10.1080/19420862.2023.2211692
work_keys_str_mv AT antunesana 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT alvarezvallinaluis 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT bertogliofederico 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT bouquinnicolas 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT cornenstephanie 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT duffieuxfrancis 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT ferrepierre 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT gilletraphaelle 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT jorgensenchristian 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT leickmarkb 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT maillerebernard 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT negrehelene 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT pelegrinmireia 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT poiriernicolas 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT reuschdietmar 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT robertbruno 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT serreguy 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT vicarialain 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT villalbamartin 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT volperschristoph 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT vuddamalaygavin 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT watierherve 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT wurchthierry 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT zabeaulennart 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT zielonkastefan 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT zhangbaolin 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT beckalain 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies
AT martineaupierre 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies